IS5012A - Alendrónat vökvasamsetningar - Google Patents

Alendrónat vökvasamsetningar

Info

Publication number
IS5012A
IS5012A IS5012A IS5012A IS5012A IS 5012 A IS5012 A IS 5012A IS 5012 A IS5012 A IS 5012A IS 5012 A IS5012 A IS 5012A IS 5012 A IS5012 A IS 5012A
Authority
IS
Iceland
Prior art keywords
alendronate
fluid compositions
compositions
fluid
alendronate fluid
Prior art date
Application number
IS5012A
Other languages
English (en)
Icelandic (is)
Inventor
J. Nerurkar Maneesh
A. Hunke William
Ostovic Drazen
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9700541.7A external-priority patent/GB9700541D0/en
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of IS5012A publication Critical patent/IS5012A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS5012A 1996-10-04 1999-03-26 Alendrónat vökvasamsetningar IS5012A (is)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2676596P 1996-10-04 1996-10-04
GBGB9700541.7A GB9700541D0 (en) 1997-01-13 1997-01-13 Liquid alendronate formulation
US3600297P 1997-01-22 1997-01-22
PCT/US1997/015740 WO1998014196A1 (en) 1996-10-04 1997-10-02 Liquid alendronate formulations

Publications (1)

Publication Number Publication Date
IS5012A true IS5012A (is) 1999-03-26

Family

ID=27268667

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5012A IS5012A (is) 1996-10-04 1999-03-26 Alendrónat vökvasamsetningar

Country Status (20)

Country Link
EP (1) EP1007054A4 (ru)
JP (1) JP2001501222A (ru)
CN (1) CN1238691A (ru)
AU (1) AU723357B2 (ru)
BG (1) BG103306A (ru)
BR (1) BR9712197A (ru)
CA (1) CA2267370A1 (ru)
CZ (1) CZ116999A3 (ru)
EA (1) EA001213B1 (ru)
EE (1) EE03669B1 (ru)
HU (1) HUP0000125A3 (ru)
IL (1) IL129127A0 (ru)
IS (1) IS5012A (ru)
NO (1) NO991569L (ru)
NZ (1) NZ334836A (ru)
PL (1) PL332496A1 (ru)
SK (1) SK42999A3 (ru)
TR (1) TR199900730T2 (ru)
WO (1) WO1998014196A1 (ru)
YU (1) YU17499A (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7560490B2 (en) * 2001-01-23 2009-07-14 Gador S.A. Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US7473684B2 (en) 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
JP2009508834A (ja) * 2005-09-16 2009-03-05 セラマイン リミテッド ビスホスホネート製剤
JP2010043119A (ja) * 2009-10-16 2010-02-25 Gador Sa 骨の代謝病の予防および/または治療のための組成物、その組成物の調製方法およびその使用
US8568747B1 (en) 2012-10-05 2013-10-29 Silvergate Pharmaceuticals, Inc. Enalapril compositions
US9463183B1 (en) 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
US9669008B1 (en) 2016-03-18 2017-06-06 Silvergate Pharmaceuticals, Inc. Enalapril formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206209A (en) * 1978-11-02 1980-06-03 Kracauer Paul Sublingual aspirin tablet
IT1201087B (it) * 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
US4922007A (en) * 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
FR2703590B1 (fr) * 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
US5510517A (en) * 1993-08-25 1996-04-23 Merck & Co., Inc. Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
US5780455A (en) * 1994-08-24 1998-07-14 Merck & Co., Inc. Intravenous alendronate formulations
US5616571A (en) * 1995-06-06 1997-04-01 Merck & Co., Inc. Bisphosphonates prevent bone loss associated with immunosuppressive therapy

Also Published As

Publication number Publication date
TR199900730T2 (xx) 1999-07-21
YU17499A (en) 1999-11-22
SK42999A3 (en) 2000-01-18
EA001213B1 (ru) 2000-12-25
EA199900352A1 (ru) 1999-08-26
EE03669B1 (et) 2002-04-15
CZ116999A3 (cs) 1999-09-15
IL129127A0 (en) 2000-02-17
BG103306A (en) 2000-01-31
AU723357B2 (en) 2000-08-24
EP1007054A4 (en) 2000-07-19
WO1998014196A1 (en) 1998-04-09
CA2267370A1 (en) 1998-04-09
NO991569L (no) 1999-06-04
PL332496A1 (en) 1999-09-13
BR9712197A (pt) 1999-08-31
EE9900113A (et) 1999-10-15
AU4644897A (en) 1998-04-24
EP1007054A1 (en) 2000-06-14
NZ334836A (en) 2000-11-24
HUP0000125A2 (hu) 2000-06-28
NO991569D0 (no) 1999-03-30
CN1238691A (zh) 1999-12-15
JP2001501222A (ja) 2001-01-30
HUP0000125A3 (en) 2001-04-28

Similar Documents

Publication Publication Date Title
DE69715036D1 (de) Flüssigkeitsverbindungen
ID22931A (id) Komposisi-komposisi herbisidal
DE69803761D1 (de) Schmierölzusammensetzungen
DK1298194T3 (da) Staniolholdige sammensætninger
FI974241A0 (fi) BPM-15 -koostumukset
ATE242971T1 (de) Pestizide zusammensetzungen
BR9710090A (pt) Composições pesticidas
ID17241A (id) Komposisi-komposisi pestisida
DE69809982D1 (de) Dichtungszusammensetzungen
ID16251A (id) Komposisi-komposisi pembasmi kuman
ATE209959T1 (de) Mikroverkapselte zusammensetzungen
ATE293672T1 (de) Farbschonende zusammensetzungen
DE69719442D1 (de) Frisierschaum-Zusammensetzungen
ATE245356T1 (de) Pestizidzusammensetzungen
DE69617029D1 (de) Organoton-zusammensetzungen
ID25650A (id) Komposisi-komposisi sampo
IS5012A (is) Alendrónat vökvasamsetningar
DE69702001D1 (de) Beschichtungszusammensetzungen
DE69826706D1 (de) Wäscheweichmittelzusammensetzungen
DK0867470T3 (da) Inulinbaserede hydrokolloidsammensætninger
DE69815138D1 (de) Phosphoniumsalz-zusammensetzung
ID23520A (id) Cairan komposisi pembersih berair
DE69603228D1 (de) Aluminoxanate-Zusammensetzungen
MA23731A1 (fr) Compositions detegentes
ATE206150T1 (de) Farbstoffstabilisierte zusammensetzungen